Hangzhou Minsheng Healthcare Co (SZSE:301507) Total Payout Ratio : 0.00 (As of May. 27, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Hangzhou Minsheng Healthcare Co's current Total Payout Ratio is 0.00.

Hangzhou Minsheng Healthcare Co Total Payout Ratio Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co Total Payout Ratio Chart

Hangzhou Minsheng Healthcare Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

Get a 7-Day Free Trial

0.05

0.04

2.14

Hangzhou Minsheng Healthcare Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Payout Ratio	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Hangzhou Minsheng Healthcare Co's Total Payout Ratio

For the Drug Manufacturers - General subindustry, Hangzhou Minsheng Healthcare Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Minsheng Healthcare Co's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Minsheng Healthcare Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Minsheng Healthcare Co's Total Payout Ratio falls into.

Hangzhou Minsheng Healthcare Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Hangzhou Minsheng Healthcare Co's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	85.634
	=	0.00

Hangzhou Minsheng Healthcare Co's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	58.872
	=	0.00

Hangzhou Minsheng Healthcare Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100

Website

http://www.21vita.com

Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines